Cache Advisors LLC Increases Stock Holdings in Axon Enterprise, Inc $AXON

Cache Advisors LLC boosted its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 363.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,182 shares of the biotechnology company’s stock after purchasing an additional 3,279 shares during the period. Axon Enterprise comprises 0.3% of Cache Advisors LLC’s holdings, making the stock its 27th largest position. Cache Advisors LLC’s holdings in Axon Enterprise were worth $2,375,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. NEOS Investment Management LLC grew its holdings in shares of Axon Enterprise by 82.7% during the 3rd quarter. NEOS Investment Management LLC now owns 25,369 shares of the biotechnology company’s stock valued at $18,206,000 after purchasing an additional 11,482 shares during the last quarter. Vanguard Group Inc. grew its position in Axon Enterprise by 4.2% during the 3rd quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock worth $6,684,217,000 after acquiring an additional 376,904 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. grew its position in Axon Enterprise by 3.3% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 184,423 shares of the biotechnology company’s stock worth $132,349,000 after acquiring an additional 5,953 shares during the last quarter. Legal & General Group Plc grew its position in Axon Enterprise by 3.1% during the 3rd quarter. Legal & General Group Plc now owns 421,114 shares of the biotechnology company’s stock worth $302,208,000 after acquiring an additional 12,736 shares during the last quarter. Finally, BIT Capital GmbH grew its position in Axon Enterprise by 75.6% during the 3rd quarter. BIT Capital GmbH now owns 3,535 shares of the biotechnology company’s stock worth $2,537,000 after acquiring an additional 1,522 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Northcoast Research upgraded Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 price target on the stock in a research report on Tuesday, January 6th. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Morgan Stanley cut their price target on shares of Axon Enterprise from $713.00 to $675.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. Piper Sandler cut their price target on shares of Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. Finally, Wall Street Zen raised shares of Axon Enterprise from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. Sixteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $755.88.

Insider Activity at Axon Enterprise

In related news, Director Jeri Williams sold 157 shares of the stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $490.00, for a total transaction of $76,930.00. Following the transaction, the director owned 1,159 shares in the company, valued at $567,910. This represents a 11.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Erika Nardini sold 198 shares of the stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $506.58, for a total value of $100,302.84. Following the completion of the transaction, the director directly owned 1,946 shares in the company, valued at approximately $985,804.68. This represents a 9.24% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 13,855 shares of company stock valued at $7,109,828 over the last quarter. 4.40% of the stock is owned by company insiders.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Wall Street reaffirmations and bullish notes today helped lift the stock — several firms kept Buy ratings even after trimming targets, and at least three analysts issued supportive notes amid Axon Week. Axon Enterprise stock rises 4% on analyst optimism
• Positive Sentiment: Product news: Axon unveiled an AI suite (Axon Vision, expanded Axon Assistant, Axon 911) designed to stitch live video, 911 data and field reporting — a potential revenue and stickiness driver if agencies adopt it. Investors reacted positively to the AI roadmap. Can Axon’s New AI Suite Reframe Its Real-Time Data Advantage Story for Investors (AXON)?
• Positive Sentiment: Conference buzz: coverage and writeups of Axon Week boosted sentiment as the company positioned AI as a differentiator for real‑time public‑safety data — helping justify optimistic analyst views on longer‑term growth. Axon shares rebound after AI product push at annual conference
• Neutral Sentiment: Price‑target resets: several firms trimmed targets (Goldman and TD Cowen among them) but left Buy ratings — the cuts reduce near‑term upside expectations but signal continued confidence in the story. Price target coverage (Benzinga)
• Negative Sentiment: Recent selloff and legal risk: shares plunged ~10% on Tuesday after news of new legal exposure around Axon’s HQ and broader market weakness; that event created the pullback that analysts are now calling a buying opportunity. Why Axon (AXON) Shares Are Trading Lower Today
• Negative Sentiment: Volatility risk: the stock’s high valuation (elevated P/E) and recent headline-driven swings increase downside risk if product adoption or legal outcomes disappoint. Axon Stock Plunged on Tuesday. Is This a Buying Opportunity?

Axon Enterprise Trading Up 5.0%

NASDAQ:AXON opened at $391.53 on Thursday. Axon Enterprise, Inc has a one year low of $362.73 and a one year high of $885.91. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 2.29. The company’s 50-day simple moving average is $470.33 and its 200 day simple moving average is $571.34. The firm has a market capitalization of $31.48 billion, a P/E ratio of 257.59, a PEG ratio of 8.81 and a beta of 1.61.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, topping the consensus estimate of $1.60 by $0.55. The business had revenue of $796.72 million for the quarter, compared to the consensus estimate of $755.29 million. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The company’s revenue for the quarter was up 38.5% compared to the same quarter last year. During the same period in the previous year, the company posted $2.08 earnings per share. As a group, analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.